References

• American Society of Addiction Medicine. (2023). The ASAM criteria: Treatment criteria for addictive, substance-related, and co-occurring conditions (4th ed., Vol. 1). Hazelden Publishing.
• David, A. R., Sian, C. R., Gebel, C. M., Linas, B. P., Samet, J. H., Sprague Martinez, L. S., Muroff, J., Bernstein, J. A., & Assoumou, S. A. (2022). Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study. Journal of Substance Abuse Treatment, 142, 108870. https://doi.org/10.1016/j.jsat.2022.108870
• Kreek, M. J., Reed, B., & Butelman, E. R. (2019). Current status of opioid addiction treatment and related preclinical research. Science Advances, 5(10), eaax9140. https://doi.org/10.1126/sciadv.aax9140
• Kreek, M. J., & Vocci, F. J. (2002). History and current status of opioid maintenance treatments: blending conference session. Journal of substance abuse treatment, 23(2), 93–105. https://doi.org/10.1016/s0740-5472(02)00259-3
• Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews, 2009(3), Article CD002209. https://doi.org/10.1002/14651858.CD002209.pub2
• McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA, 284(13), 1689–1695. https://doi.org/10.1001/jama.284.13.1689
• Saitz, R., Larson, M. J., Labelle, C., Richardson, J., & Samet, J. H. (2008). The case for chronic disease management for addiction. Journal of Addiction Medicine, 2(2), 55–65. https://doi.org/10.1097/ADM.0b013e318166af74
• Savinkina, A., Madushani, R. W. M. A., Eftekhari Yazdi, G., Wang, J., Barocas, J. A., Morgan, J. R., Assoumou, S. A., Walley, A. Y., Linas, B. P., & Murphy, S. M. (2022). Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: An effectiveness and cost-effectiveness analysis. Addiction, 117, 2450–2461. https://doi.org/10.1111/add.15879
• Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020). Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Network Open, 3(2), e1920622. https://doi.org/10.1001/jamanetworkopen.2019.20622